(Q40778493)

23 September 2017

title

Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity (English)

1 reference

23 September 2017

1 reference

L Yin

1

1 reference

23 September 2017

G Laevsky

series ordinal

2

1 reference

23 September 2017

C Giardina

series ordinal

3

1 reference

23 September 2017

language of work or name

English

0 references

publication date

25 September 2001

1 reference

Journal of Biological Chemistry

23 September 2017

published in

1 reference

23 September 2017

volume

276

1 reference

23 September 2017

issue

48

1 reference

23 September 2017

page(s)

44641-44646

1 reference

The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis?

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Butyrate and the colonocyte. Implications for neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Fiber-derived butyrate and the prevention of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Withdrawal of butyrate from the colonic mucosa triggers "mass apoptosis" primarily in the G0/G1 phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Enhanced apoptosis in transformed human lung fibroblasts after exposure to sodium butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Are dietary fiber-induced alterations in colonic epithelial cell proliferation predictive of fiber's effect on colon cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Rationale for the luminal provision of butyrate in intestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

The effect of sodium butyrate on histone modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Regulation of activity of the transcription factor GATA-1 by acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Deacetylation of p53 modulates its effect on cell growth and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Ubiquitin-dependent degradation of IkappaBalpha is mediated by a ubiquitin ligase Skp1/Cul 1/F-box protein FWD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkappaBalpha turnover.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Novel IkappaB alpha proteolytic pathway in WEHI231 immature B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Proteasome inhibition: a new strategy in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

I kappa B: a specific inhibitor of the NF-kappa B transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Role of short-chain fatty acids in the prevention of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Effect of organic acid absorption on bicarbonate transport in rat colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Modulation of glutathione level during butyrate-induced differentiation in human colon derived HT-29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Nonsteroidal anti-inflammatory drugs, short-chain fatty acids, and reactive oxygen metabolism in human colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Regulation of C-fos expression by sodium butyrate in the human colon carcinoma cell line Caco-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Regulation of c-myc expression by sodium butyrate in the colon carcinoma cell line Caco-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Ileal and colonic epithelial metabolism in quiescent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Proteolysis: The proteasome: a protein-degrading organelle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Poly-ADP ribose polymerase activates nuclear proteasome to degrade oxidatively damaged histones

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Proteasome inhibitors: valuable new tools for cell biologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Effect of dietary fiber on colonic cell proliferation and its relationship to colon carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Inhibitory effect of microfibril wheat bran on azoxymethane-induced colon carcinogenesis in CF1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

The ubiquitin-mediated proteolytic pathway as a therapeutic area

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Roles of ubiquitin-mediated proteolysis in cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

beta-catenin is a target for the ubiquitin-proteasome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Apoptosis induction resulting from proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Control of gene expression by proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

Regulation of p53 stability by Mdm2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

The ubiquitin-proteasome pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M105170200

21 January 2018

Identifiers

DOI

10.1074/JBC.M105170200

1 reference

23 September 2017

1 reference